Valomaciclovir: Phase II started

Epiphany began a double-blind, placebo-controlled, U.S. Phase II trial. Medivir granted Epiphany worldwide rights outside the Nordic countries to valomaciclovir (see BioCentury, Sept 6, 2006). ...